The lawyers at VERBA LEGAL provide comprehensive legal support to pharmaceutical companies, medical device manufacturers, distributors, pharmacy chains, private medical organizations, companies in the digital health sector, as well as leading FMCG holdings.
The team specializes in comprehensive legal solutions in the field of circulation of medicinal products, medical devices and FMCG products, transactions with pharmaceutical assets of any type, data protection and processing, and structuring of industry compliance systems.
The team of more than 20 specialists represents one of the largest practices with industry expertise in the legal market. Over the past few years, the practice specialists have implemented more than 1,000 projects for industry clients.
The head of the practice, Alexander Panov, is a member of the expert council of the Healthcare Committee of the Federation Council. Among the clients are more than 100 companies, including Binnopharm Group, Pfizer, Viatris, Heel, CooperVision, AbbVie, Sanofi, Straumann, and others.
Selected Experience
we advised:
a large international biotechnology company on business scaling matters;
a client on issues related to promotion and market access strategies for medicinal products, including review of all promotional and advertising texts, images, software solutions, websites, advertising materials for healthcare professionals, etc., as well as related pricing mechanisms and promotion strategies in the hospital channel;
a pharmaceutical company on personal data processing issues, various formats of interaction with healthcare professionals, antitrust matters and legal regulation of adjacent products, in preparation for the launch of a dietary supplements product line;
one of the largest pharmaceutical companies in the process of preparing a strategy for challenging a tender related to procurement disputes;
a client in the pharmaceutical industry on participation in a tender for concluding a contract with counter investment obligations (offset contract), including a detailed description of the client’s obligations and risks;
a pharmaceutical manufacturer in the course of localization of production in the Russian Federation due to difficulties in ensuring product supply from Europe;
a pharmaceutical company on assessing all applicable risks in relation to a series of distribution agreements with Chinese manufacturing partners; within this work, the firm’s legal team not only addressed complex regulatory aspects of the transaction, but also assessed customs, tax risks, as well as risks related to intellectual property and product pricing;
one of the largest Russian pharmaceutical companies on implementing a strategy for entering the Middle East and Southeast Asia markets through regulatory actions, corporate structuring based on the client’s needs, and selection of the necessary tools for the fastest possible market entry;
due diligence of a private healthcare company, which included verification of compliance with licensing requirements, legal aspects of quality of medical care, relations with the territorial compulsory medical insurance fund, as well as assessment of risks related to commercial contracts, taxes, and other applicable risks;
a multidisciplinary clinic specializing in high-tech medical services on the opening of a multidisciplinary clinic in Dubai and the development of medical tourism;
one of the leading groups of companies in the private healthcare market in Russia on implementing NIPT — prenatal and postnatal testing for detecting genetic diseases — into its product line;
a client in the implementation of a project for establishing an experimental legal regime (ELR) in the field of big medical data for their subsequent use, in particular for training artificial intelligence and its application in the provision of medical care.